LIAONING MEDICAL DIAGNOSIS AND TREATMENT TECHNOLOGY R AND D CENTER CO LTD

Overview

LIAONING MEDICAL DIAGNOSIS AND TREATMENT TECHNOLOGY R AND D CENTER CO LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL EXOSOMES; NK-LIKE T CELL EXOSOMES.

API / Drug Master Files

LIAONING MEDICAL DIAGNOSIS AND TREATMENT TECHNOLOGY R AND D CENTER CO LTD holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL EXOSOMESActive2025-11-24
• NK-LIKE T CELL EXOSOMESActive2025-03-31

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LIAONING MEDICAL DIAGNOSIS AND TREATMENT TECHNOLOGY R AND D CENTER CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.